New Topical Therapies for Psoriasis and Atopic Dermatitis
Dr. Bhutani presented new topical therapies for psoriasis and atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib.
3 Years, 3 Investigators, $1 Million Donation
Three extraordinary mid-career investigators with established trajectories of excellence in basic, translational and clinical research will receive DF funding through its DF Research Award Program, now enhanced with the BMS million-dollar donation.
Probing Skin’s Microbiome
The Sun Pharma Research Award provides Dr. Tiffany Scharschmidt with the focus and freedom to address clinically translational aspects of her research in pediatric atopic dermatitis.